Elite Diagnostic Limited (JMSE:ELITE)

Market Cap	551.30M
Revenue (ttm)	868.26M
Net Income (ttm)	55.56M
Shares Out	353.40M
EPS (ttm)	0.16
PE Ratio	9.92
Forward PE	n/a
Dividend	0.01 (0.64%)
Ex-Dividend Date	Sep 19, 2025

Volume	28,436
Average Volume	204,347
Open	n/a
Previous Close	1.510
Day's Range	1.450 - 1.560
52-Week Range	1.450 - 2.000
Beta	-0.09
RSI	51.05
Earnings Date	Feb 12, 2026

About Elite Diagnostic

Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. The company medical imaging services, including CT scan, MRI, x-ray, ultrasound, and fluoroscopy services. It also provides interventional procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In 2025, Elite Diagnostic's revenue was 853.82 million, an increase of 3.96% compared to the previous year's 821.28 million. Earnings were 32.02 million, an increase of 22.44%.